Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance)
- Citation:
- Clin Cancer Res vol 21 (23) 5294-5304
- Year:
- 2015
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- 2130 is parent abstract
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 5
- Parents:
- 1003
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Correl Sci NOS
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171, CA33601, U10 CA031946, U10 CA033601, U10 CA180821, U24 CA114740, CA-114740, CA-25224, U10 CA180850, K05 CA-142885, U10 CA180790, P30 CA015083, U10 CA180882, U24 CA196171, K05 CA142885, U10 CA025224, CA31946
- Corr. Author:
- Authors:
- Frank A. Sinicrope Michelle R. Mahoney Harry H. Yoon Thomas C. Smyrk Stephen N. Thibodeau Richard M. Goldberg Garth D. Nelson Daniel J. Sargent Steven R. Alberts
- Networks:
- LAPS-MN026, LAPS-OH007
- Study
- NCCTG-N0147
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- colon cancer, adjuvant, tumor site, BRAF, KRAS, MSI, prognosis